ATC Group: D01BA01 Griseofulvin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D01BA01 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D01 Antifungals for dermatological use
3 D01B Antifungals for systemic use
4 D01BA Antifungals for systemic use
5 D01BA01 Griseofulvin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.5 g

Active ingredients in D01BA01

Active Ingredient Description
Griseofulvin

Related product monographs

Title Information Source Document Type  
MEDOFULVIN Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Brazil (BR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Hong Kong (HK)

Italy (IT)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.